Currie A C, Brigic A, Thomas-Gibson S, Suzuki N, Moorghen M, Jenkins J T, Faiz O D, Kennedy R H
Department of Surgery, St Mark's Hospital and Academic Institute, Harrow, Middlesex, UK.
Wolfson Department of Endoscopy, St Mark's Hospital and Academic Institute, Harrow, Middlesex, UK; Department of Surgery and Cancer, Imperial College London, London, UK.
Eur J Surg Oncol. 2017 Nov;43(11):2044-2051. doi: 10.1016/j.ejso.2017.05.026. Epub 2017 Aug 23.
Previous attempts at sentinel lymph node (SLN) mapping in colon cancer have been compromised by ineffective tracers and the inclusion of advanced disease. This study evaluated the feasibility of fluorescence detection of SLNs with indocyanine green (ICG) for lymphatic mapping in T1/T2 clinically staged colonic malignancy.
Consecutive patients with clinical T1/T2 stage colon cancer underwent endoscopic peritumoral submucosal injection of indocyanine green (ICG) for fluorescence detection of SLN using a near-infrared (NIR) camera. All patients underwent laparoscopic complete mesocolic excision surgery. Detection rate and sensitivity of the NIR-ICG technique were the study endpoints.
Thirty patients mean age = 68 years [range = 38-80], mean BMI = 26.2 (IQR = 24.7-28.6) were studied. Mesocolic sentinel nodes (median = 3/patient) were detected by fluorescence within the standard resection field in 27/30 patients. Overall, ten patients had lymph node metastases, with one of these patients having a failed SLN procedure. Of the 27 patients with completed SLN mapping, nine patients had histologically positive lymph nodes containing malignancy. 3/9 had positive SLNs with 6 false negatives. In five of these false negative patients, tumours were larger than 35 mm with four also being T3/T4.
ICG mapping with NIR fluorescence allowed mesenteric detection of SLNs in clinical T1/T2 stage colonic cancer. CLINICALTRIALS.GOV: ID: NCT01662752.
先前在结肠癌前哨淋巴结(SLN)定位方面的尝试因示踪剂效果不佳以及纳入了晚期疾病而受到影响。本研究评估了使用吲哚菁绿(ICG)进行荧光检测SLN用于T1/T2临床分期结肠恶性肿瘤淋巴绘图的可行性。
连续的临床T1/T2期结肠癌患者接受内镜下肿瘤周围黏膜下注射吲哚菁绿(ICG),使用近红外(NIR)相机进行SLN的荧光检测。所有患者均接受腹腔镜完整结肠系膜切除术。NIR-ICG技术的检测率和敏感性为研究终点。
研究了30例患者,平均年龄 = 68岁[范围 = 38 - 80岁],平均BMI = 26.2(IQR = 24.7 - 28.6)。在27/30例患者的标准切除野内通过荧光检测到结肠系膜前哨淋巴结(中位数 = 3/患者)。总体而言,10例患者有淋巴结转移,其中1例患者前哨淋巴结定位失败。在27例完成前哨淋巴结定位的患者中,9例患者组织学检查显示淋巴结有恶性肿瘤。9例中有3例前哨淋巴结阳性,6例假阴性。在这6例假阴性患者中,5例肿瘤大于35mm,4例为T3/T4期。
NIR荧光ICG绘图可在临床T1/T2期结肠癌中实现肠系膜前哨淋巴结的检测。临床试验注册中心:ID:NCT01662752。